My standards for skincare are high, and few things clear the bar. I have spent enough time in clinical medicine and longevity research to be deeply sceptical of the gap between marketing language and actual mechanism. The beauty industry runs on compelling narratives built on thin science. Adding the word “longevity” to product ranges in recent years has done little to improve matters. Most of the time, it is brand positioning, not biology.
That is why what I found at Lancôme’s research laboratory in Paris was worth paying attention to. The science around urolithin A skin longevity is further along than I expected — and that is what I want to explain.
The compound at the centre of it
The new Absolue Longevity MD range centres on Mitopure®, Timeline’s highly purified, 98.5% pure form of urolithin A. I know this compound well. It is not new to me, and it is not new to the longevity field — I already take it orally as part of my own protocol. The question the range poses is whether urolithin A skin longevity effects are achievable topically, through the same mitochondrial mechanism that operates systemically.
Urolithin A is a postbiotic compound produced when certain gut bacteria metabolise ellagitannins, polyphenols found in pomegranates, berries, and walnuts. The conversion is highly dependent on individual microbiome composition. Research suggests only around 40% of people produce meaningful amounts naturally, regardless of how much of the relevant foods they eat. Mitopure bypasses this variability entirely, delivering a standardised, directly bioavailable form of the compound.
Its primary mechanism is the stimulation of mitophagy: the selective cellular process by which the body identifies, clears, and replaces damaged or dysfunctional mitochondria. Think of it as cellular housekeeping for the body’s own energy generators. As we age, this process becomes progressively less efficient. The accumulation of damaged mitochondria drives cellular ageing, reduced energy production, and increased vulnerability to oxidative stress.
Behind Mitopure sits more than 15 years of research and over $50 million in R&D investment. The oral evidence base is serious, covering improvements in muscle function, mitochondrial health markers, and cellular energy in clinical studies. Applying it topically, in a skincare context, is a genuinely interesting development that follows coherent biological logic.
Why urolithin A skin longevity science matters
The skin is a metabolically active organ, in constant conversation with the body’s energy systems, inflammatory signals, hormonal environment, and oxidative stress load. When mitochondrial function declines in skin cells, the consequences are visible and measurable: reduced collagen synthesis, slower cell turnover, impaired barrier function, and diminished capacity to repair UV damage.
Better mitochondrial function means more cellular energy — more ATP available for the repair and renewal processes that keep skin resilient and youthful in function, not merely in appearance. The Lancôme formulation works through the same mitochondrial pathway as the oral supplement, but at the level of the skin’s own cellular machinery.
A randomised clinical trial published in medRxiv found reduced markers of intrinsic skin ageing and meaningful protection from UVB-mediated photodamage. This is the core of the urolithin A skin longevity argument: not theoretical benefit, but measurable, replicable findings in humans.
The Absolue Longevity MD trials reported up to a 50% reduction in skin oxidation, with a 16% reduction in incoming fine lines. These are numbers worth respecting if the methodology is sound, and from what I saw at the lab, the investment in clinical validation is real.
Why this matters more at my life stage
I am approaching 50. Between London and significant international travel, my skin carries a meaningful oxidative load. And I am in perimenopause.
That last factor is the most clinically relevant. Oestrogen plays a direct, well-documented role in skin biology: it stimulates collagen synthesis, regulates hydration, supports wound healing, and modulates the skin’s inflammatory response. As oestrogen declines during perimenopause, every one of these processes is affected. Research consistently finds that women lose up to 30% of their dermal collagen within the first five years following menopause. This is a dramatic structural change. Surface-level skincare alone cannot reverse it, but cellular-level support can meaningfully slow it.
For skin already challenged by hormonal withdrawal, urban pollution, and years of training and sun exposure, supporting mitochondrial function is not a luxury. It is one of the most logical interventions available.
Having urolithin A working from both directions — orally, supporting mitochondrial health systemically, and topically, delivering it directly to skin cells — is, for me, a logical doubling down on urolithin A skin longevity. The same compound, addressing the same cellular mechanism, through two complementary routes.
The diagnostic piece that genuinely impressed me
Beyond the formulation itself, what impressed me most at the Lancôme lab was the Cell BioPrint technology. This diagnostic tool reads protein markers on the skin’s surface to estimate its biological age in approximately fifteen minutes. It is available in-store at Harrods and Selfridges.
The reason this matters is simple: it addresses one of the fundamental problems in skincare, which is the absence of objective measurement. Most people assess skincare efficacy by subjective impression. Does my skin look better? Do I feel better about it? These are valid experiences, but placebo effect, lighting, stress levels, hydration, and a dozen other variables all distort them.
Establishing a baseline biological age for the skin, then tracking change over time using protein markers rather than visual assessment, shifts the conversation from anecdote to data. The impulse is the same as blood biomarker testing in preventive medicine: measure what is happening at a cellular level rather than relying on surface impressions.
One important caveat: Cell BioPrint measures skin biological age specifically, not whole-body biological age. The two should not be conflated. As a way of tracking the skin’s response to interventions over time, though, it represents a meaningful advance on what has previously existed in a consumer context.
How I use it
My practical note, for anyone investing in this range: apply it after a bath, hot shower, or sauna session, while the skin is warm and slightly damp. Temporary vasodilation increases blood flow to the skin’s surface, and follicular openings expand briefly. Both of these improve penetration of active ingredients significantly, including larger molecules like those in sophisticated skincare formulations. This is a simple, cost-free adjustment that makes a genuine difference to efficacy.
I approach skincare with the same framework I apply to clinical decisions: mechanism first, evidence second, experience third. This range, unusually, clears all three bars.
I visited Lancôme’s research laboratory in Paris to assess the science behind the Absolue Longevity MD range independently. I take Mitopure orally as part of my own longevity protocol. All views are my own clinical assessment.
Comments will display here